Most patients experience minimal to no adverse effects
This, in turn, boosts metabolic rate and activates a gene known as sirtuin-1 (SIRT1), also referred to as the "longevity gene." SIRT1 is involved in reducing the risk of various conditions such as diabetes, obesity, metabolic syndrome, atherosclerosis, cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer.
BPC-157 Not FDA-approved
A 1,000-microgram tablet would be expected to result in a 10 to 20-microgram dose
doi:10.3390/jcm13082176
Outcome signal Focus support Evidence cue Neuro research Decision rhythm Start / Compare / Explore Best-fit signals Choose Selank when these match your goal Decision timeline What to expect as you compare Selank Timelines vary by goal, dose, baseline health, and consistency